Rowinsky Eric K
SEC CIK 1318886 · EDGAR
BoughtSold
Most active insiders at BIIB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Singhal Priya | Head of Development | — | $665.7K |
| 2 | Minor Lloyd | Dir | — | $239.7K |
| 3 | Murphy Nicole | Head of Pharm Ops, Tech | $585.12 | — |
| 4 | Godbout Sean | CAO | — | — |
| 5 | Pangalos Menelas N | Dir | — | — |
| 6 | Grogan Jane | Head of Research | — | — |
| 7 | LANGER SUSAN | Dir | — | — |
| 8 | Keeney Adam | Head of Corp. Development | — | — |
| 9 | Izzar Rachid | Head of Gbl Product Strat | — | — |
| 10 | Patolawala Monish D | Dir | — | — |
| 16 | Rowinsky Eric K | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-11 17:46 | 2026-06-09 | BIIB | Biogen | Rowinsky Eric K | Dir | A - Grant | $0.00 | +1,505 | 25.8K | +6% | $0 | |
| 2026-05-26 18:21 | 2026-05-21 | VSTM | Verastem, Inc. | Rowinsky Eric K | Dir | A - Grant | $0.00 | +36.0K | 52.7K | +216% | $0 | |
| 2025-06-18 | 2025-06-17 | BIIB | Biogen | Rowinsky Eric K | Dir | A - Grant | $0.00 | +2,370 | 24.3K | +11% | $0 | |
| D | 2025-05-27 | 2025-05-22 | VSTM | Verastem, Inc. | Rowinsky Eric K | Dir | A - Grant | $0.00 | +8,333 | 16.7K | +100% | $0 |
| 2024-06-25 | 2024-06-21 | BIIB | Biogen | Rowinsky Eric K | Dir | A - Grant | $0.00 | +1,340 | 22.0K | +6% | $0 | |
| D | 2024-06-20 | 2024-06-18 | VSTM | Verastem, Inc. | Rowinsky Eric K | Dir | A - Grant | $0.00 | +8,333 | 8,333 | New | $0 |
| 2024-02-20 | 2024-02-15 | BIIB | Biogen | Rowinsky Eric K | Dir | P - Purchase | $222.54 | +455 | 20.6K | +2% | +$101.3K | |
| I | 2024-01-24 | 2017-09-05 | VSTM | Verastem, Inc. | Rowinsky Eric K | Dir | P - Purchase | $3.84 | +2,000 | 2,000 | New | +$7,680 |
| 2024-01-03 | 2024-01-01 | FBIO | Fortress Biotech, Inc. | Rowinsky Eric K | Dir | A - Grant | $0.00 | +6,666 | 68.8K | +11% | $0 | |
| 2023-06-28 | 2023-06-26 | BIIB | Biogen | Rowinsky Eric K | Dir | A - Grant | $0.00 | +960 | 20.2K | +5% | $0 | |
| 2023-02-14 | 2023-02-10 | FBIO | Fortress Biotech, Inc. | Rowinsky Eric K | Dir | P - Purchase | $0.84 | +12.0K | 932.0K | +1% | +$10.1K | |
| 2023-01-04 | 2023-01-01 | FBIO | Fortress Biotech, Inc. | Rowinsky Eric K | Dir | A - Grant | $0.00 | +100.0K | 920.0K | +12% | $0 | |
| 2022-06-17 | 2022-06-15 | BIIB | Biogen | Rowinsky Eric K | Dir | A - Grant | $0.00 | +1,370 | 19.2K | +8% | $0 | |
| 2022-04-29 | 2022-01-01 | FBIO | Fortress Biotech, Inc. | Rowinsky Eric K | Dir | A - Grant | $0.00 | +100.0K | 820.0K | +14% | $0 | |
| 2021-07-02 | 2021-07-01 | BIIB | Biogen | Rowinsky Eric K | Dir | A - Grant | $0.00 | +775 | 17.8K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations